Albaal M, Bshara N
Department of Pediatric Dentistry, Faculty of Dental Medicine, Damascus University, Damascus, Syria, Damascus, Syrian Arab Republic.
Eur Arch Paediatr Dent. 2025 Sep 18. doi: 10.1007/s40368-025-01113-7.
This study evaluated augmented reality (AR) headsets' effectiveness in reducing anxiety and pain in children (7-9 years) during intraoral injections.
One hundred eight children were randomized to four groups: Control (cartoons on a mobile device during injection), Group A (cartoons via AR headset during injection), Group B (AR games before being transported to the dental chair), and Group C (AR games before plus cartoons during injection). Anxiety was assessed by Venham's Picture Test (VPT) and heart rate (HR) monitoring; pain was measured with the FLACC Behavioral Pain Assessment Scale and the Wong-Baker FACES Pain Rating Scale.
Post-injection, VPT mean ranks were significantly lower in Groups A (46.59), B (42.83), and C (40.41) compared to the Control group (65.17; P < 0.05). HR monitoring revealed a significant increase during injection in the Control group (107.6 ± 15.7 bpm) and Group A (106.6 ± 13.2 bpm) compared with Groups B (94.7 ± 8.0 bpm) and C (91.4 ± 9.8 bpm; P < 0.05). Severe pain (WBF score ≥ 8) was reported by 18.5% in the Control group versus none in the test groups (P < 0.05). Similarly, FLACC scores indicated the highest discomfort in the Control group, with no severe discomfort observed in Groups A, B, or C (P < 0.05).
AR headsets significantly reduce injection-related anxiety and eliminate severe pain behaviors in children, providing pediatric dental practitioners with a low-cost, easily implemented tool to enhance patient comfort and cooperation. The study was registered at ClinicalTrials.gov (NCT06724341).
本研究评估了增强现实(AR)头显在减轻儿童(7至9岁)口腔内注射时的焦虑和疼痛方面的有效性。
108名儿童被随机分为四组:对照组(注射期间在移动设备上播放卡通片)、A组(注射期间通过AR头显观看卡通片)、B组(在被送往牙科椅之前玩AR游戏)和C组(在被送往牙科椅之前玩AR游戏,且注射期间观看卡通片)。通过韦纳姆图片测试(VPT)和心率(HR)监测评估焦虑;使用面部表情疼痛评分量表(FLACC)和面部表情疼痛评分量表(Wong-Baker FACES)测量疼痛。
注射后,与对照组(65.17)相比,A组(46.59)、B组(42.83)和C组(40.41)的VPT平均秩显著更低(P < 0.05)。心率监测显示,与B组(94.7 ± 8.0次/分钟)和C组(91.4 ± 9.8次/分钟)相比,对照组(107.6 ± 15.7次/分钟)和A组(106.6 ± 13.2次/分钟)在注射期间心率显著增加(P < 0.05)。对照组中有18.5%的儿童报告有严重疼痛(WBF评分≥8),而测试组中无一人报告(P < 0.05)。同样,FLACC评分显示对照组的不适感最高,A组、B组或C组均未观察到严重不适(P < 0.05)。
AR头显可显著减轻儿童与注射相关的焦虑,并消除严重的疼痛行为,为儿科牙科医生提供了一种低成本、易于实施的工具,以提高患者的舒适度和合作度。该研究已在ClinicalTrials.gov注册(NCT06724341)。